Skip to content
Search AI Powered

Latest Stories

WHO calls for action to protect children from contaminated medicines after cough syrups deaths

In October 2022, it issued an alert over Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup manufactured by Maiden Pharmaceuticals Limited, Haryana, India.

WHO calls for action to protect children from contaminated medicines after cough syrups deaths

In the wake of fatalities among children linked to cough syrups and medicines made by manufacturers based in India and Indonesia, the WHO has issued an "urgent call to action” to countries to detect and respond to incidents of falsified medical products and protect children from contaminated medicines.

The World Health Organisation (WHO) said that over the past four months, countries reported several incidents of over-the-counter cough syrups for children with confirmed or suspected contamination with high levels of diethylene glycol (DEG) and ethylene glycol (EG).


The cases are from at least seven countries, associated with more than 300 fatalities in three of these countries, with most young children under the age of five. The WHO said the contaminants are toxic chemicals used as industrial solvents and antifreeze agents that can be fatal even in small amounts, and should never be found in medicines.

“WHO is releasing an urgent call to action to countries to prevent, detect and respond to incidents of substandard and falsified medical products,” the global health agency said.

Since October last year, the WHO has issued three global medical alerts over substandard paediatric medicines and syrups.

In October 2022, it issued an alert over Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup manufactured by Maiden Pharmaceuticals Limited, Haryana, India.

The four “substandard products” were identified in the Gambia and reported to the WHO in September 2022.

In November, an alert was issued by the WHO over eight products, including Unibebi Cough Syrup, Unibebi Demam Paracetamol Drops and Unibebi Demam Paracetamol Syrup, identified in Indonesia and manufactured by PT Afi Farma.

Earlier this month, the WHO issued an alert to warn against the use of two “substandard” cough syrups manufactured by Marion Biotech, India that have been linked to the deaths of 18 children in Uzbekistan.

Ambronol syrup and DOK-1 Max syrup were manufactured by Marion Biotech, based in Noida, Uttar Pradesh.

The global health organisation issued the alert saying the syrups fail to meet quality standards and contain contaminants that can prove fatal.

The WHO’s medical product alerts were rapidly disseminated to the national health authorities of all 194 WHO Member States.

These medical product alerts requested the detection and removal of contaminated medicines from circulation in the markets; increased surveillance and diligence within the supply chains of countries and regions likely to be affected; immediate notification to WHO if these substandard products are discovered in-country; and otherwise inform the public of the dangers and toxic effects of the substandard medicines at issue.

It noted that since these are not isolated incidents, the WHO called on regulators and governments to detect and remove from circulation in their respective markets any substandard medical products that have been identified in the alerts as potential causes of death and disease; ensure that all medical products in their respective markets are approved for sale by competent authorities and obtainable from authorised/licensed suppliers.

It also urged authorities to assign appropriate resources to improve and increase risk-based inspections of manufacturing sites within their jurisdiction in accordance with international norms and standards and enact and enforce laws and other relevant legal measures to help combat the manufacture, distribution and/or use of substandard and falsified medicines.

The WHO called on manufacturers of medicines to only purchase pharmaceutical grade excipients from qualified and bona fide suppliers; conduct comprehensive testing upon receipt of supplies and before use in the manufacture of finished products and provide assurance of product quality including through certificates of analyses based on appropriate testing results.

It also urged suppliers and distributors of medical products to always check for signs of falsification and physical condition of medicines and other health products they distribute and/or sell and only distribute and/or sell medicines authorised by, and from sources approved by, competent authorities among other measures.

In December, India's drug regulator told the WHO that the global health body drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.

In a letter to Dr Rogerio Gaspar, Director (Regulation and Prequalification) at WHO, DCGI Dr V G Somani said a statement issued by the global health body in October in the wake of the deaths "was unfortunately amplified by the global media which led to a narrative being built internationally targeting the quality of Indian pharmaceutical products".

(PTI)

More For You

Sara Sharif e1692881096452

Sara was discovered dead in her bunkbed on 10 August 2023.

Sara was discovered dead in her bunkbed on 10 August 2023.

'Chatterbox with biggest smile': Headteacher pays tribute to Sara Sharif

SARA SHARIF, a ten-year-old girl who suffered fatal abuse at the hands of her father and stepmother, is being remembered as a cheerful and caring pupil with a love for singing.

Her father, Urfan Sharif, 42, and stepmother, Beinash Batool, 30, were found guilty on 11 December of her murder at their home in Woking, Surrey, on 8 August 2023. Sara’s uncle, Faisal Malik, 29, was convicted of causing or allowing the death of a child.

Keep ReadingShow less
Healthcare workers hold placards as they demonstrate on Westminster Bridge, near to St Thomas' Hospital in London on May 1, 2023. (Photo: Getty Images)
Healthcare workers hold placards as they demonstrate on Westminster Bridge, near to St Thomas' Hospital in London on May 1, 2023. (Photo: Getty Images)

Teachers, nurses warn of strikes over 2.8 per cent pay rise proposal

TEACHERS and nurses may strike after the government recommended a 2.8 per cent pay rise for public sector workers for the next financial year.

Ministers cautioned that higher pay awards would require cuts in Whitehall budgets.

Keep ReadingShow less
A man walks past a mural that says ‘Northern Ireland’, on Sandy Row in Belfast, Northern Ireland, August 11, 2024. (Photo: Reuters)
A man walks past a mural that says ‘Northern Ireland’, on Sandy Row in Belfast, Northern Ireland, August 11, 2024. (Photo: Reuters)

Northern Ireland approves extension of post-Brexit trade rules

NORTHERN Ireland’s devolved government has voted to continue implementing post-Brexit trading arrangements under the Windsor Framework, a deal signed between London and the European Union in February 2023.

The vote in the Northern Ireland Assembly at Stormont extended the arrangement for four years.

Keep ReadingShow less
'Covid bereavement rates in Scotland highest among Asians'
Ethnic groups were found to be two-and-a-half times more likely to have experienced the loss of a close family member.

'Covid bereavement rates in Scotland highest among Asians'

THE bereavement rates due to Covid in Scotland have been highest among those identifying with ‘Any other’ ethnic group (68 per cent), followed by Indians (44 per cent) and Pakistanis (38 per cent), a new study revealed. This is significantly higher than the national average of around 25 per cent.

Ethnic groups were found to be two-and-a-half times more likely to have experienced the loss of a close family member during the Covid crisis.

Keep ReadingShow less
Harmeet Dhillon gives a benediction at the end of the first day of the 2024 Republican National Convention at the Fiserv Forum in Milwaukee, Wisconsin,  on July 15, 2024. (Photo: Getty Images)
Harmeet Dhillon gives a benediction at the end of the first day of the 2024 Republican National Convention at the Fiserv Forum in Milwaukee, Wisconsin, on July 15, 2024. (Photo: Getty Images)

Trump nominates Harmeet Dhillon for top Department of Justice role

US PRESIDENT-ELECT Donald Trump has nominated Indian-American attorney Harmeet K Dhillon as assistant attorney general for civil rights at the Department of Justice.

“I am pleased to nominate Harmeet K Dhillon as assistant attorney general for civil rights at the US Department of Justice,” Trump announced on Monday on Truth Social, his social media platform.

Keep ReadingShow less